Treatment of pain in methadone-maintained patients.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 11064492)

Published in Mt Sinai J Med on December 01, 2000

Authors

M M Scimeca1, S R Savage, R Portenoy, J Lowinson

Author Affiliations

1: Department of Addiction Medicine, St. Barnabas Hospital, Third Avenue and 183rd Street, Bronx, NY 10457-2594, USA.

Articles citing this

Challenges in using opioids to treat pain in persons with substance use disorders. Addict Sci Clin Pract (2008) 1.81

Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med (2006) 1.56

Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol (2008) 1.32

Allopathic, complementary, and alternative medical treatment utilization for pain among methadone-maintained patients. Am J Addict (2009) 1.08

Gabapentin improves cold-pressor pain responses in methadone-maintained patients. Drug Alcohol Depend (2010) 0.92

Hyperalgesia in heroin dependent patients and the effects of opioid substitution therapy. J Pain (2012) 0.89

Pharmacological pain control for human immunodeficiency virus-infected adults with a history of drug dependence. J Subst Abuse Treat (2007) 0.87

Lack of effect of chronic dextromethorphan on experimental pain tolerance in methadone-maintained patients. Addict Biol (2008) 0.84

Successful Pain Management for the Recovering Addicted Patient. Prim Care Companion J Clin Psychiatry (2002) 0.83

Pain Among High-Risk Patients on Methadone Maintenance Treatment. J Pain (2015) 0.82

Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy. Am J Drug Alcohol Abuse (2009) 0.82

The glycosylation of AGP and its associations with the binding to methadone. Biomed Res Int (2013) 0.76

[Pain therapy in addicted patients]. Schmerz (2006) 0.75

Caring for patients with opioid use disorder in the hospital. CMAJ (2016) 0.75

Articles by these authors

Pain management and chemical dependency. Evolving perspectives. JAMA (1997) 2.89

Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck (1997) 1.71

Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol (1990) 1.57

The narcotic-dependent mother: fetal and neonatal consequences. Early Hum Dev (1977) 1.40

Pain as a predictor of outcome in patients with operable pancreatic carcinoma. Surgery (1997) 1.40

Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology (Berl) (1990) 1.32

Differential effects of maternal heroin and methadone use on birthweight. Pediatrics (1976) 1.28

Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward. Life Sci (1995) 1.22

American Academy of Pediatrics Report of the Subcommittee on Assessment and Methodologic Issues in the Management of Pain in Childhood Cancer. Pediatrics (1990) 0.98

Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor. J Natl Cancer Inst (1995) 0.95

Detoxification of long-term methadone patients: problems and prospects. Int J Addict (1976) 0.93

Prevalence of anemia in cancer patients undergoing radiation therapy. Semin Oncol (2001) 0.90

L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysis. Ann N Y Acad Sci (2004) 0.89

Acquired immune deficiency syndrome and multiple tract degeneration in a homosexual man. Ann Neurol (1984) 0.88

Methadone treatment and physical complaints: a clinical analysis. Int J Addict (1981) 0.85

Three oral formulations of methadone. A clinical and pharmacodynamic comparison. J Subst Abuse Treat (1999) 0.82

Clinical realities and economic considerations: special therapeutic issues in intrathecal therapy--tolerance and addiction. J Pain Symptom Manage (1997) 0.82

A model for the treatment of cancer pain. J Pain Symptom Manage (1986) 0.80

Clinical analgesic assay of repeated and single doses of heroin and hydromorphone. Pain (1990) 0.80

An exploratory study of frequent pain measurement in a cancer clinical trial. Qual Life Res (1996) 0.79

Differential effects of heroin and methadone on birth weights. Addict Dis (1975) 0.79

Delirium as a contributing factor to "crescendo" pain: three case reports. J Pain Symptom Manage (1994) 0.79

Development and validation of a patient needs assessment tool (PNAT) for oncology clinicians. Cancer Nurs (1996) 0.79

Social rehabilitation of addicts: a two-year evaluation. Int J Addict (1977) 0.76

Group therapy in the treatment of the juvenile narcotic addict. Int Pharmacopsychiatry (1972) 0.75

Legal services as a tool in treating the addict. Am J Psychiatry (1973) 0.75

Locus of control and initiation of detoxification among male methadone maintenance patients. Int J Addict (1983) 0.75

Detoxification of multiple-drug abusers with sodium amytal. N Y State J Med (1972) 0.75

Stress coping skills for the dental profession. J Tenn Dent Assoc (1983) 0.75

Rehabilitation of the Puerto Rican addict: a cultural perspective. Int J Addict (1981) 0.75

Drug therapy for cancer pain. Am J Hosp Palliat Care (1993) 0.75

Changes in AIDS risk behavior among intravenous drug abusers in New York City. N Y State J Med (1990) 0.75

Detoxification from methadone: results and inferences. Curr Psychiatr Ther (1978) 0.75